eGFP/Firefly Luciferase K562 Cell Line
The eGFP/Firefly Luciferase K562 Cell Line are engineered human lymphoblast K562 cells expressing firefly luciferase and enhanced GFP (eGFP) driven by an EF1a promoter. The cells were generated by transduction with Firefly Luciferase-eGFP Lentivirus (BPS Bioscience #78741), which is a SIN (self-inactivating) lentivirus.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
Name | Ordering Information |
Thaw Medium 2 | BPS Bioscience #60184 |
Growth Medium 2D | BPS Bioscience #79639 |
The cell line has been screened to confirm the absence of Mycoplasma species.
The K562 cell line was established from a patient with chronic myelogenous leukemia (CML) in terminal blast crisis. The K562 Cell Line does not express antigens CD19, CD20 or CD22, therefore it makes an excellent negative control in assays that measure specific killing by CAR-T cells targeting B cell antigens CD19, CD20, and CD22. It can also be used as a highly sensitive in vitro target in natural killer assays. The presence of eGFP and luciferase allows for easy assay readouts, making this cell line a convenient choice.